Fentanyl citrate oral transmucosal lozenge, 800 mcg (W6369-22-A061/A)
Process Number PW-21-00973917
Dates:
2021-11-05 00:00:00
Amendment date:None
Date closing:2022/01/11 14:00 Eastern Standard Time (EST)
Details:
Ontario
Department of National Defence
Department of National Defence
National Capital Region
Open
PW-21-00973917
W6369-22-A061/A
Description:
The Strategic Medical Countermeasures Program (SMCP) on behalf of the Canadian Forces Health Services Group (CF H Svcs Gp), Department of National Defence (DND), has a requirement for fentanyl citrate oral transmucosal lozenges for the treatment of Canadian Armed Forces (CAF) members injured in the course of military training or operations. Requested contract period is from Contract Award to 31 March 2025 with options to procure additional quantities over the course of the contract period. The Initial Requirement is for 510 lozenges to be delivered no later than 31 March 2022, with options to procure additional lozenges as follows: a) Optional Requirement 1 (Year 1): If exercised, the Contractor must supply up to 1,020 lozenges no later than 31 March 2023. b) Optional Requirement 2 (Year 2): If exercised, the Contractor must supply up to 1,020 lozenges no later than 31 March 2024 c) Optional Requirement 3 (Year 3): If exercised, the Contractor must supply up to 1,020 lozenges no later than 31 March 2025.
Contact information:
Payeur, Marie-diane
Contact email:Marie-Diane.Payeur@forces.gc.ca
Contact phone:819-939-8469
105 Hotel de Ville Gatineau QC K1O 0K2 CA
Contact Fax:Solicitation Documents:
| File | Amendment Number | Language | Date added |
|---|---|---|---|
| w6369-22-a061_rfp.pdf | 000 | English | 2021-11-05 |
| w6369-22-a061_rfp_french.pdf | 000 | French | 2021-11-05 |